- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Enzalutamide – November 2015
Enzalutamide: capsules, 40 mg, Xtandi®
Last updated
18 March 2016